OBJECTIVES: To assess the risk of @entity86 associated with blood transfusion in @entity1 who undergo primary total hip arthroplasty. DESIGN: A retrospective cohort study. SETTING: Victoria General Hospital, Halifax, (a tertiary-care centre). @entity1 : All @entity1 who underwent primary total hip replacement between 1990 and 1995 (N = 1206). INTERVENTIONS: Hip replacement with or without perioperative blood transfusion. OUTCOME MEASURES: The rate of @entity86 , the number of blood transfusions, @entity1 age and sex, duration of surgery and the surgeon who performed the procedure. Victoria General Hospital medical records, the transfusion services record and the Dalhousie University Hip Study databases were integrated and analyzed using a standard statistical package. RESULTS: The incidence of @entity281 postoperative was 9.9% overall, 8.4% in @entity1 receiving no transfusion, and 14% in those receiving homologous transfusion (p = 0.035). There were no infections in the 11 @entity1 who received an autologous blood transfusion. Significant predictors of @entity86 were sex, age and duration surgery; these were not confounding variables multivariate analysis). Neither the operating surgeon nor the blood product transfused affected the @entity281 rate. CONCLUSIONS: These findings suggest an increased risk of @entity86 in @entity1 who undergo primary hip replacement and receive homologous blood transfusions perioperatively.

Is homologous blood transfusion a risk factor for XXXX after hip replacement?

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity86 :: ('MESH:D019106', 'Disease') :: ['postoperative infection']
@entity281 :: (MESH:D007239,Disease) :: ['infection']
